ALION SCIENCE & TECHNOLOGY CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-20: Form 8-K; Period of report 2010-12-20; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 2.02.
- 2010-11-09: Form 8-K; Period of report 2010-09-30; Description 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 3.02.
- 2010-10-04: Form 8-K; Period of report 2010-09-30; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
- 2010-08-24: Form 8-K; Period of report 2010-08-24; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-12-20 | 8-K | 2010-12-20 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events | 2.02 The information in this report set forth under Item 7.01 is incorporated herein by reference. 7.01 Alion Science and Technology Corporation (Alion or the Company) intends to disclose on December 21, 2010, the following non-public information. 8.01 Alion will host a conference call on December 21, 2010 at 10:00 a.m. | c10019e8vk.htm |
| 2010-11-09 | 8-K | 2010-09-30 | 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 8.01 Other Events | 3.02 On October 4, 2010, Alion Science and Technology Corporation ("Alion" or the "Company") filed a current report on Form 8-K to report the September 30, 2010 sale of approximately $1.9 million of common stock to the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust (the "Trust"). 7.01 Alion Science and Technology Corporation ("Alion" or the "Company") intends to disclose on November 10, 2010, the following non-public information. 8.01 State Street Bank and Trust Company, as trustee ("the Trustee") of the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan (the "ESOP"), has selected a final value of $26.65 per share for Alion’s common stock as of September 30, 2010 (the "Valuation Date"). | htm_39668.htm |
| 2010-10-04 | 8-K | 2010-09-30 | 3.02 Unregistered Sales of Equity Securities | 3.02 On September 30, 2010, Alion Science and Technology Corporation (the “Company”) sold approximately $1.9 million of common stock to the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust (the “ESOP trust”). | c06566e8vk.htm |
| 2010-08-24 | 8-K | 2010-08-24 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events | 2.02 The information in this report set forth under Item 7.01 is incorporated herein by reference. 7.01 Alion Science and Technology Corporation (Alion or the Company) intends to disclose on August 25, 2010, the following non-public information. 8.01 Alion will host a conference call on August 25, 2010 at 4:00 p.m. | c05361e8vk.htm |
| 2010-07-22 | 8-K | 2010-07-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of July 16, 2010, General Michael V. Hayden, (Ret.) was elected to the Board of Directors of Alion Science and Technology Corporation (the “Registrant”) and was appointed to the Registrant’s Corporate Governance and Compliance Committee. | c03713e8vk.htm |
| 2010-05-20 | 8-K | 2010-05-20 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The information in this report set forth under Item 7.01 is incorporated herein by reference. 7.01 Alion Science and Technology Corporation (Alion or the Company) disclosed during a conference call held on May 20, 2010, the following non-public information. | c01518e8vk.htm |
| 2010-05-18 | 8-K | 2010-05-18 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events | 2.02 The information in this report set forth under Item 7.01 is incorporated herein by reference. 7.01 Alion Science and Technology Corporation (Alion or the Company) intends to disclose on May 20, 2010, the following non-public information. 8.01 Alion will host a conference call on May 20, 2010 at 1:30 p.m. | c01358e8vk.htm |
| 2010-05-13 | 8-K | 2010-03-31 | 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 3.02 Alion Science and Technology Corporation (“Alion” or the “Company”) determined that based on a March 31, 2010 valuation of the Company’s common stock presented to the Company’s Board of Directors on May 11, 2010, that it sold approximately 76,003 shares to the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust (the “Trust”) at $28.00 per share (the “Per Share Price”) for aggregate proceeds of approximately $2.1 million. 8.01 State Street Bank and Trust Company, the ESOP Trustee, retained an independent third-party valuation firm to help it determine (the “March 31 Price”). | c01078e8vk.htm |
| 2010-03-25 | 8-K/A | 2010-03-11 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 On March 11, 2010, Alion Science and Technology Corporation (“Alion” or the “Company”) entered into a Purchase Agreement (the “Purchase Agreement”) with Credit Suisse Securities (USA) LLC (the “Initial Purchaser”), to sell to the Initial Purchaser 310,000 of the Company’s units (the “Units”), each Unit consisting of $1,000 principal amount of the Company’s 12% Senior Secured Notes due November 1, 2014 (the “Secured Notes”) and one detachable warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase approximately 1.9439 shares of common stock, par value $0.01 per share, of the Company. 1.02 As previously disclosed, on December 21, 2009, the Company entered into a Note and Warrant Redemption Agreement, Fourth Amendment to Seller Note Securities Purchase Agreement, First Amendment to the Second Amended and Restated Seller Note and Rights Agreement Termination Agreement (the “Redemption Agreement”) dated as of December 18, 2009 between the Company and IIT. 2.03 The disclosure required by this item is included in Item 1.01 and is incorporated herein by reference. 3.02 The disclosure required by this item is included in Item 1.01 and is incorporated herein by reference. 5.03 On March 18, 2010, the board of directors of the Company adopted the Amended and Restated By-Laws, which became effective on such date (the “Amended and Restated By-Laws”). | w77843ae8vkza.htm |
| 2010-03-22 | 8-K | 2010-03-11 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 On March 11, 2010, Alion Science and Technology Corporation (“Alion” or the “Company”) entered into a Purchase Agreement (the “Purchase Agreement”) with Credit Suisse Securities (USA) LLC (the “Initial Purchaser”), to sell to the Initial Purchaser 310,000 of the Company’s units (the “Units”), each Unit consisting of $1,000 principal amount of the Company’s 12% Senior Secured Notes due November 1, 2014 (the “Secured Notes”) and one detachable warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase approximately 1.9439 shares of common stock, par value $0.01 per share, of the Company. 1.02 As previously disclosed, on December 21, 2009, the Company entered into a Note and Warrant Redemption Agreement, Fourth Amendment to Seller Note Securities Purchase Agreement, First Amendment to the Second Amended and Restated Seller Note and Rights Agreement Termination Agreement (the “Redemption Agreement”) dated as of December 18, 2009 between the Company and IIT. 2.03 The disclosure required by this item is included in Item 1.01 and is incorporated herein by reference. 3.02 The disclosure required by this item is included in Item 1.01 and is incorporated herein by reference. 5.03 On March 18, 2010, the board of directors of the Company adopted the Amended and Restated By-Laws, which became effective on such date (the “Amended and Restated By-Laws”). | w77843e8vk.htm |
| 2010-03-08 | 8-K | 2010-03-08 | 7.01 Regulation FD Disclosure | 7.01 The Company’s Consolidated EBITDA compound annual growth rate from fiscal year 2005 to fiscal year 2009 was 10.3%. | w77632e8vk.htm |
| 2010-03-05 | 8-K | 2010-03-05 | 8.01 Other Events | 8.01 On March 5, 2010, Alion Science and Technology Corporation (“Alion”, the “Company”) issued a press release announcing that it plans to issue units (the “Units”) consisting of $300 million aggregate principal amount of Senior Secured Notes due November 2014 (the “Notes”) and warrants (the “Warrants”) to purchase shares of Alion common stock. | w77622e8vk.htm |
| 2010-03-03 | 8-K | 2010-03-02 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | c97190e8vk.htm |
| 2010-02-04 | 8-K | 2010-02-01 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On February 1, 2010, James C. Fontana resigned his position as General Counsel of the Registrant. | htm_36150.htm |
| 2010-01-29 | 8-K | 2010-01-29 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The information in this report set forth under Item 7.01 is incorporated herein by reference. 7.01 Alion Science and Technology Corporation (Alion, the Company) is furnishing the following non-public information related to the Company’s compliance with certain financial covenants in its outstanding Senior Credit Facility. | c95150e8vk.htm |
| 2010-01-05 | 8-K | 2010-01-05 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 The information in this report set forth under Item 7.01 is incorporated herein by reference. 7.01 Alion Science and Technology Corporation (Alion, the Company) is furnishing the following non-public information related to the Company’s compliance with certain financial covenants in its outstanding Senior Credit Facility. | c94273e8vk.htm |